Starting a general discussion on M7T, as I think it is an interesting company, I don't know much about it and I haven't come across anyone who does.

Of course, the point I missed in my Straw this morning, is that one reason for the discount to valuation is the lumpiness of revenue that is realised on big contracts that follow the capital model. But we are seeing a continuation of the ternds towards subsciption and in in FY22 went well past 50%. So earning quality will improve over time.

A few questions on my mind:

• Don't know much about management or Board, although CEO is experienced, having been CEO of Imaging On Call from 2008-2011 (it was acquired at then end of 2010)
• Not sure what to make of the share register. Holdings by insiders less than we'd hope for
• Don't really understand how its offering in the market differs from $PME from a functionality perspective

What am I missing? Or if this continues to grow for another year or two, is it going to pop up on everyone's radar when the search begins again in earnest for good growth stocks.